Long-Term Administration of Queen Bee Acid (QBA) to Rodents Reduces Anxiety-Like Behavior, Promotes Neuronal Health and Improves Body Composition

Nutrients. 2017 Dec 23;10(1):13. doi: 10.3390/nu10010013.

Abstract

Background: Queen bee acid (QBA; 10-hydroxy-2-decenoic acid) is the predominant fatty acid in royal jelly (RJ) and has activity at estrogen receptors, which affect brain function and body composition. However, few, long-term studies have assessed QBA effects in brain health and body composition.

Methods: Primary hippocampal neurons were treated with QBA (0-30 µM) and challenged with glutamate or hypoxia. QBA was fed to aged, male Sprague-Dawley rats (12-24 mg/kg/day) and to adult male and female Balb/C mice (30-60 mg/kg/day) for ≥3.5 months. Rats were evaluated in a behavioral test battery of brain function. Mice were measured for fat and muscle composition, as well as bone density.

Results: QBA increased neuron growth and protected against glutamate challenge and hypoxia challenge. Rats receiving QBA had reduced anxiety-like behavior, increased body weight, and better maintenance of body weight with age. Mice receiving QBA exhibited increased body weight, muscle mass, and adiposity in males, and increased bone density, but decreased adiposity, in females.

Conclusions: QBA is an active component of RJ that promotes the growth and protection of neurons, reduces anxiety-like phenotypes, and benefits bone, muscle and adipose tissues in a sex-dependent manner, which further implicates estrogen receptors in the effects of QBA.

Keywords: behavior; body composition; mood; neuroprotection; queen bee acid.

MeSH terms

  • Adiposity / drug effects
  • Animals
  • Anti-Anxiety Agents / isolation & purification
  • Anti-Anxiety Agents / pharmacology*
  • Anxiety / pathology
  • Anxiety / physiopathology
  • Anxiety / prevention & control*
  • Anxiety / psychology
  • Behavior, Animal / drug effects*
  • Body Composition / drug effects*
  • Bone Density / drug effects
  • Cell Hypoxia
  • Cells, Cultured
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Exploratory Behavior / drug effects
  • Fatty Acids / chemistry*
  • Fatty Acids, Monounsaturated / isolation & purification
  • Fatty Acids, Monounsaturated / pharmacology*
  • Female
  • Glutamic Acid / toxicity
  • Hippocampus / drug effects*
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Locomotion / drug effects
  • Male
  • Maze Learning / drug effects
  • Mice, Inbred BALB C
  • Neurons / drug effects*
  • Neurons / pathology
  • Neuroprotective Agents / isolation & purification
  • Neuroprotective Agents / pharmacology*
  • Rats, Sprague-Dawley
  • Sex Factors
  • Time Factors
  • Weight Gain / drug effects

Substances

  • Anti-Anxiety Agents
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Neuroprotective Agents
  • Glutamic Acid
  • 10-hydroxy-2-decenoic acid
  • royal jelly